Skip to content

Bladder Papillary Urothelial Neoplasm C1511197

Published: July 22, 2026Updated: August 20, 2026

A bladder tumor with papillary growth patterns, ranging from low-grade lesions with good prognosis to higher-risk neoplasms.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
C80.1
ICD-11
2A00.0
Body system
oncologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(oncologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Painless hematuria

(urinary)

Urinary frequency

(urinary)

Dysuria

(urinary)

Flank pain

(urinary)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Exercise prescription and weight management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Transurethral resection of bladder tumor

Endoscopic surgical procedure using a resectoscope inserted through the urethra to remove visible bladder tumors and obtain tissue samples for pathological examination and staging.

surgical
3

Fluorescence cystoscopy

Enhanced visualization technique using photosensitizing agents and blue light during cystoscopy to improve detection of flat or subtle lesions that may be missed with standard white-light cystoscopy.

procedure

Additional treatment options

Intravesical BCG immunotherapy

Installation of Bacillus Calmette-Guérin live attenuated vaccine directly into the bladder via catheter to stimulate local immune response and reduce tumor recurrence in high-risk non-muscle-invasive bladder cancer.

medication

Routine cystoscopic surveillance

Regular follow-up cystoscopy examinations at scheduled intervals to detect tumor recurrence early, with frequency based on initial tumor grade and risk classification.

monitoring

Smoking cessation

Comprehensive tobacco cessation program addressing smoking as the primary modifiable risk factor for bladder cancer development and recurrence, using counseling, nicotine replacement, and pharmacotherapy.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Bladder Papillary Urothelial Neoplasm C1511197?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat Bladder Papillary Urothelial Neoplasm C1511197. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy